rs375292548
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_001171613.2(PREPL):c.1598G>T(p.Arg533Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,606,356 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R533C) has been classified as Uncertain significance.
Frequency
Consequence
NM_001171613.2 missense
Scores
Clinical Significance
Conservation
Publications
- hypotonia-cystinuria syndromeInheritance: AR Classification: STRONG Submitted by: G2P
- myasthenic syndrome, congenital, 22Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000198 AC: 30AN: 151876Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000153 AC: 38AN: 248420 AF XY: 0.000127 show subpopulations
GnomAD4 exome AF: 0.000117 AC: 170AN: 1454364Hom.: 1 Cov.: 30 AF XY: 0.000102 AC XY: 74AN XY: 723720 show subpopulations
GnomAD4 genome AF: 0.000197 AC: 30AN: 151992Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74288 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1865G>T (p.R622L) alteration is located in exon 11 (coding exon 11) of the PREPL gene. This alteration results from a G to T substitution at nucleotide position 1865, causing the arginine (R) at amino acid position 622 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Myasthenic syndrome, congenital, 22 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at